These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 3920903)

  • 1. ABC analysis of the relationship between pharmacy charges and DRGs.
    Magee MJ; Pathak DS; Sherrin TP; Schneider DN
    Am J Hosp Pharm; 1985 Mar; 42(3):571-6. PubMed ID: 3920903
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analyzing pharmacy charges using DRGs.
    Catania HF; Ibrahim OM; Guasco SL; Catania PN
    Am J Hosp Pharm; 1984 May; 41(5):920-3. PubMed ID: 6428225
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of nationwide pharmacy charges per DRG.
    Curtiss FR
    Am J Hosp Pharm; 1985 Oct; 42(10):2168-74. PubMed ID: 3933336
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An analysis of hospital case mix, cost, and payment differences for Medicare, Medicaid, and Blue Cross Plan patients using DRGs.
    Martin SG; Frick AP; Shwartz M
    Inquiry; 1984; 21(4):369-79. PubMed ID: 6240468
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of pharmacist participation on a medical team on costs, charges, and length of stay.
    Haig GM; Kiser LA
    Am J Hosp Pharm; 1991 Jul; 48(7):1457-62. PubMed ID: 1882873
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Creating standard treatment protocols: an analysis of pharmacy charges as an aid in their development.
    Boothe CD; Ferencz N
    Hosp Formul; 1987 Oct; 22(10):873-5, 879-81. PubMed ID: 10312221
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of length of stay and total hospital charges with antimicrobial regimen changes.
    Raisch DW; Bootman JL; McGhan WF
    Am J Hosp Pharm; 1988 Apr; 45(4):819-23. PubMed ID: 3132038
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of drug costs within diagnosis related groups.
    Kolar R; Stanaszek W; Osborne J; Dougherty K
    Hosp Pharm; 1984 Nov; 19(11):731-5. PubMed ID: 10310864
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiple-regression hospitalization-cost model for pharmacy cost analysis.
    Phillips MS; Bradham DD; Williams RB; Petry ML
    Am J Hosp Pharm; 1986 Mar; 43(3):676-81. PubMed ID: 3085484
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Do older Medicare patients cost hospitals more? Evidence from an academic medical center.
    Rosenthal GE; Landefeld CS
    Arch Intern Med; 1993 Jan; 153(1):89-96. PubMed ID: 8422203
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Measuring severity of illness to predict patient resource use within DRGs.
    Horn SD; Sharkey PD
    Inquiry; 1983; 20(4):314-21. PubMed ID: 6229481
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Evaluating the first German diagnosis-related groups (G-DRG) in cardiological patients: problems in the correct medical and economic grouping].
    Reinecke H; Bunzemeier H; Fürstenberg T; Rothenburger M; Böcker D; Scheld HH; Breithardt G; Roeder N
    Z Kardiol; 2003 Jul; 92(7):581-94. PubMed ID: 12883843
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interhospital variations in hospital pharmacy markups.
    Johnston WP; Jacobs P; Dickson M
    Am J Hosp Pharm; 1985 Nov; 42(11):2492-5. PubMed ID: 3907337
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of DRGs and cost-containment: assessment by hospital pharmacy directors.
    McGhan WF; Larson LN; Raisch DW
    Hosp Formul; 1986 Aug; 21(8):870-1, 874-6. PubMed ID: 10311626
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Third-party reimbursement for clinical pharmacy services: philosophy and practice.
    Nold EG; Pathak DS
    Am J Hosp Pharm; 1977 Aug; 34(8):823-6. PubMed ID: 900133
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Case-mix adjustment using objective measures of severity: the case for laboratory data.
    Mozes B; Easterling MJ; Sheiner LB; Melmon KL; Kline R; Goldman ES; Brown AN
    Health Serv Res; 1994 Feb; 28(6):689-712. PubMed ID: 8113053
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Charging for hospital pharmaceutical services: combined product-service per diem fees.
    Dirks I; Pang FJ
    Am J Hosp Pharm; 1979 Mar; 36(3):363-5. PubMed ID: 420230
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hospital charges: analysis and comparison.
    Sear AM
    Health Care Manage Rev; 1989; 14(1):49-54. PubMed ID: 2494131
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost of comprehensive pharmaceutical services in a 45-bed rural hospital.
    Nelson AA; Tindall WN; Gourley DR; Arrigo J; Anderson RJ
    Am J Hosp Pharm; 1976 Nov; 33(11):1149-53. PubMed ID: 998632
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Part one: How do hospital directors plan to cope with the constraints of DRGs?
    Lantos RL
    Pharm Times; 1984 Apr; 50(4):66, 68-9. PubMed ID: 10310561
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.